₹7.26
▲ +0.14 +1.97%
17 Jul 2026
BSE Listed
GSM 0 · ESM 1Hindustan Bio Sciences Ltd. (532041)
Volume: 5Avg Vol 1W: 6,697Avg Vol 1M: 6,51552W Range:₹5₹9.92
Key Ratios
Checked just nowMarket Cap₹7 Cr
Current Price₹7.26
Previous Close₹7.12
High / Low (52w)₹9.92 / ₹5
Volume5
Avg Vol (1W)6,697
Avg Vol (1M)6,515
Stock P/E—
Book Value₹0.81
Dividend Yield0%
ROE-9.55%
ROA-281.25%
Revenue (TTM)—
Revenue Growth—
Profit Margin-12.86%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹0
P/B8.96
Debt / Equity2.98
50 DMA₹7.93
200 DMA₹7.5
Day change+1.97%
SurveillanceGSM 0 · ESM 1 (as of 2026-07-17)
Price Chart
₹7.26▼ 19.24% · 1Y
2025-07-172026-07-17
20-day avg volume: 6K shares
Pros
- Company is almost debt-free.
- Net profit is growing year over year.
Cons
- Revenue fell 23% YoY.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| EBITDA | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Net Profit | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1 Cr | ₹4 Cr | ₹2 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| EBITDA | ₹-2 Cr | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹-1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Net Profit | ₹-2 Cr | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹-1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| EPS | -2.22 | 0.11 | 0.08 | -0.92 | -0.5 | -0.04 | 0.06 | 0.1 |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹4 Cr | ₹6 Cr | ₹6 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr |
| Total Liabilities | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr |
| Equity | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Operating | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹0 Cr |
| Investing | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Financing | ₹-1 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr |
| Free Cash Flow | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹0 Cr |
Shareholding
Promoter 12.19% Institutions 0% Public 87.81%
Efficiency & Working Capital
ROCE-2.5%
Interest Coverage0
Dividend Payout—
Debtor Days198 d
Inventory Days0 d
Payable Days0 d
Cash Conversion Cycle198 d
Working Capital Days198 d
Shareholding Details
As of 2026-03-31
Promoter12.2%
FII0%
DII0%
Institutions0%
Public87.8%
Promoter Pledge0%
No. of Shareholders11,530
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 12.2% | 12.2% | 12.2% | 12.2% | 12.2% | 12.2% | 12.2% | 12.2% | 12.2% | 12.2% | 12.2% | 12.2% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 87.8% | 87.8% | 87.8% | 87.8% | 87.8% | 87.8% | 87.8% | 87.8% | 87.8% | 87.8% | 87.8% | 87.8% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 8,853 | 9,253 | 10,315 | 10,921 | 11,779 | 11,618 | 11,276 | 11,246 | 11,620 | 11,405 | 11,516 | 11,530 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Venkata Rama Mohan Raju Jampana | Shareholding of Promoter and Promoter Group | 9.4% | 9,62,091 |
| Super Solutions India Private Limited | Shareholding of Promoter and Promoter Group | 2.8% | 2,84,815 |
| Bosco Armando Menezes | Public Shareholding | 2.6% | 2,70,000 |
| Satyasai Kolli | Public Shareholding | 2.6% | 2,65,764 |
| Emily Bosco Menezes | Public Shareholding | 2.5% | 2,55,000 |
| Madhusudan Rao Polineni | Public Shareholding | 1.6% | 1,64,600 |
| Chintalapati Deepika | Public Shareholding | 1.4% | 1,40,849 |
| Smitha Polineni | Public Shareholding | 1.1% | 1,10,817 |
| J Varun Varma | Shareholding of Promoter and Promoter Group | 0% | 2,100 |
| J Uma | Shareholding of Promoter and Promoter Group | 0% | 600 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Venkata Rama Mohan Raju Jampana | 0 | 0% | 2026-03-31 |
| J Uma | 0 | 0% | 2026-03-31 |
| J Varun Varma | 0 | 0% | 2026-03-31 |
| Super Solutions India Private Limited | 0 | 0% | 2026-03-31 |
| Bosco Armando Menezes | 0 | 0% | 2026-03-31 |
| Emily Bosco Menezes | 0 | 0% | 2026-03-31 |
| Madhusudan Rao Polineni | 0 | 0% | 2026-03-31 |
| Smitha Polineni | 0 | 0% | 2026-03-31 |
| Satyasai Kolli | 0 | 0% | 2026-03-31 |
| Chintalapati Deepika | 0 | 0% | 2026-03-31 |
| Venkata Rama Mohan Raju Jampana | 0 | 0% | 2025-12-31 |
| J Uma | 0 | 0% | 2025-12-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| J.V.R. Mohan Raju | Chairman & Managing Director | 2025 |
| J Uma | Non-Exec & Non-Independent Dir | 2025 |
| JAISON GEORGE | Non Independent Non Executive Director / CFO | 2025 |
| Reji Abraham | Independent Non Exe. Director | 2025 |
| Bodeddula Nagi Reddy | Independent Non Exe. Director | 2025 |
| Gorrela Pratheek Reddy | Independent Non Exe. Director | 2025 |
| Shailendra Vyas | Company Sec. & Compli. Officer | 2025 |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| Exports | ₹1 Cr | 100% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹2 | 2 | 2 | 2 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
Substantial Acquisitions (SAST)
2 disclosure(s)
Market22/01/2026 · 15,000
Market18/07/2024 - 19/07/2024 · 3,000
Company Information
Incorporated1991
ChairmanJ.V.R. Mohan Raju
AuditorVASG & Associates
Investor Email[email protected], pharma.hindustanbio@
📍 H No 8-2-269/S PlotNo 31 RdNo2, Sagar Co-Op Hous Banjara Hills, Hyderabad, Telangana, 500034
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search